PL2287180T3 - Pochodne Lol p 5 o zredukowanej alergeniczności i utrzymanej reaktywności dla komórek T - Google Patents

Pochodne Lol p 5 o zredukowanej alergeniczności i utrzymanej reaktywności dla komórek T

Info

Publication number
PL2287180T3
PL2287180T3 PL10009856T PL10009856T PL2287180T3 PL 2287180 T3 PL2287180 T3 PL 2287180T3 PL 10009856 T PL10009856 T PL 10009856T PL 10009856 T PL10009856 T PL 10009856T PL 2287180 T3 PL2287180 T3 PL 2287180T3
Authority
PL
Poland
Prior art keywords
lol
conserved
derivatives
reactivity
cell reactivity
Prior art date
Application number
PL10009856T
Other languages
English (en)
Inventor
Martin Wald
Oliver Cromwell
Andreas Nandy
Helga Kahlert
Bernhard Weber
Helmut Fiebig
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL2287180T3 publication Critical patent/PL2287180T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL10009856T 2003-06-04 2004-05-06 Pochodne Lol p 5 o zredukowanej alergeniczności i utrzymanej reaktywności dla komórek T PL2287180T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10325508 2003-06-04
EP10009856.5A EP2287180B9 (de) 2003-06-04 2004-05-06 Lol p 5-Derivate mit reduzierter Allergenität und erhaltener T-Zellreaktivität
EP04739147A EP1629006B1 (de) 2003-06-04 2004-05-06 Phl p 5a-derivate mit reduzierter allergenität und erhaltener t-zellreaktivität

Publications (1)

Publication Number Publication Date
PL2287180T3 true PL2287180T3 (pl) 2013-12-31

Family

ID=33494849

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10009855T PL2272863T3 (pl) 2003-06-04 2004-05-06 Pochodne poa p 5 o zredukowanej alergeniczności i zakonserwowanej reaktywności komórek t
PL10009856T PL2287180T3 (pl) 2003-06-04 2004-05-06 Pochodne Lol p 5 o zredukowanej alergeniczności i utrzymanej reaktywności dla komórek T

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL10009855T PL2272863T3 (pl) 2003-06-04 2004-05-06 Pochodne poa p 5 o zredukowanej alergeniczności i zakonserwowanej reaktywności komórek t

Country Status (13)

Country Link
US (3) US8628946B2 (pl)
EP (3) EP1629006B1 (pl)
JP (2) JP4782671B2 (pl)
CN (1) CN1798763B (pl)
AT (1) ATE513848T1 (pl)
AU (1) AU2004245184B2 (pl)
BR (1) BRPI0410908A (pl)
CA (1) CA2528053C (pl)
ES (3) ES2434720T3 (pl)
PL (2) PL2272863T3 (pl)
PT (3) PT2272863E (pl)
RU (1) RU2368620C2 (pl)
WO (1) WO2004108758A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR779201A0 (en) 2001-09-20 2001-10-11 University Of Melbourne, The Immunotherapeutic and immunoprophylactic reagents
JP4782671B2 (ja) * 2003-06-04 2011-09-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減したアレルギー誘発性および保持されたＴ細胞反応性を有するＰｈｌｐ５ａ誘導体
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
CA2786936A1 (en) 2010-01-14 2011-07-21 Merck Patent Gmbh Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues
KR20240055084A (ko) 2021-09-13 2024-04-26 라이프 테크놀로지스 코포레이션 유전자 편집 도구

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
DE19713001A1 (de) * 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
DE19918682A1 (de) * 1999-04-23 2000-10-26 Merck Patent Gmbh DNA-Sequenz und rekombinante Herstellung eines Graminaen-Allergens
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
PL214225B1 (pl) * 2000-11-16 2013-07-31 Alk Abello As Zrekombinowany alergen, zastosowanie zrekombinowanego alergenu, kompozycja farmaceutyczna, sposób przygotowania kompozycji farmaceutycznej, sposób przygotowania zrekombinowanego alergenu, sekwencja DNA kodujaca zrekombinowany alergen, wektor ekspresyjny, komórka gospodarza oraz sposób produkcji zrekombinowanego zmutowanego alergenu
AUPR779201A0 (en) * 2001-09-20 2001-10-11 University Of Melbourne, The Immunotherapeutic and immunoprophylactic reagents
JP4782671B2 (ja) * 2003-06-04 2011-09-28 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減したアレルギー誘発性および保持されたＴ細胞反応性を有するＰｈｌｐ５ａ誘導体

Also Published As

Publication number Publication date
WO2004108758A1 (de) 2004-12-16
ES2434720T3 (es) 2013-12-17
US20140255434A1 (en) 2014-09-11
PT1629006E (pt) 2011-09-28
EP2272863A1 (de) 2011-01-12
PT2272863E (pt) 2013-01-30
PT2287180E (pt) 2013-10-31
PL2272863T3 (pl) 2013-03-29
ES2367633T3 (es) 2011-11-07
US20160207967A1 (en) 2016-07-21
EP2287180B9 (de) 2013-11-06
JP4782671B2 (ja) 2011-09-28
ATE513848T1 (de) 2011-07-15
CA2528053C (en) 2014-08-12
ES2397778T3 (es) 2013-03-11
EP1629006B1 (de) 2011-06-22
JP2007536893A (ja) 2007-12-20
RU2005141524A (ru) 2006-09-10
US9522938B2 (en) 2016-12-20
US8628946B2 (en) 2014-01-14
CN1798763A (zh) 2006-07-05
US20100158955A1 (en) 2010-06-24
JP2011041566A (ja) 2011-03-03
RU2368620C2 (ru) 2009-09-27
AU2004245184B2 (en) 2011-03-24
CA2528053A1 (en) 2004-12-16
AU2004245184A1 (en) 2004-12-16
EP2287180A1 (de) 2011-02-23
EP2287180B1 (de) 2013-08-07
EP2272863B1 (de) 2012-10-31
JP5363441B2 (ja) 2013-12-11
BRPI0410908A (pt) 2006-06-27
CN1798763B (zh) 2010-05-26
EP1629006A1 (de) 2006-03-01

Similar Documents

Publication Publication Date Title
US11479605B2 (en) Homodimeric protein constructs
JP2023515386A (ja) 制御性ｔ細胞エピトープと脱寛容化ｓａｒｓ－ｃｏｖ－２抗原
AU2019377983B2 (en) Immunogenic peptides with improved oxidoreductase motifs
WO2009154995A3 (en) Interleukin 10 receptor (il-10r) antibodies and methods of use
MY149128A (en) A method for the mass production of immunoglobulin fc region deleted initial methionine residues
PT2287180E (pt) Derivados de lol p 5 com alergenicidade reduzida e reatividade mantida com as células t
DE60322225D1 (en) T-zellen-epitope in erythropoietin
EP1219301A1 (en) Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
PT1768996E (pt) Variantes dos alergénios do grupo 1 das poaceae com alergenecidade reduzida e mantendo a reactividade das células t
TW200716166A (en) Lawsonia intracellularis immunological proteins
WO2013011184A3 (es) Molécula quimerica util en inmunoterapia frente a la leishmaniosis, que comprende un fragmento de la proteina pfr1 de leishmania infantum con epitopes especificos inmunodominantes
DE602006009077D1 (de) Hiv-epitope und diese enthaltende pharmazeutische zusammensetzung
BR0312068A (pt) Sequência de dna e preparação de alérgeno de pólen de gramìneas phl p 4 por métodos recombinantes
MXPA03007002A (es) Factor estimulante de colonia de granulocitos (g-csf) modificado con inmunogenicidad reducida.
DE502004012294D1 (de) Dna-sequenz und rekombinante herstellung von gruppe-4 majorallergenen aus getreiden
WO2004113361A3 (en) Novel prokineticin receptor isoforms and methods of use
WO2007042326A3 (en) Neisseria meningitidis antigens